| Authors: |
Umehara K; Roche Pharmaceutical Research and Early Development, Roche Innovation Center, F. Hoffmann-La Roche Ltd., Basel, Switzerland. Electronic address: kenichi.umehara@roche.com., Harrell A; Bristol Myers Squibb, Pharmaceutical Candidate Optimisation, Lawrenceville, NJ, USA., Prakash C; DMPK/Clinical Pharmacology, Agios, Cambridge, MA, USA., Hilgendorf C; DMPK, Early Research and Development Cardiovascular, Renal and Metabolism BioPharmaceuticals RD, AstraZeneca, Gothenburg, Sweden., Ballard TE; Drug Metabolism, Pharmacokinetics and Modeling, Takeda Development Center Americas, Inc., Cambridge, MA, USA., Huth F; PK Sciences, BioMedical Research. Novartis, Basel, Switzerland., Badée J; PK Sciences, BioMedical Research. Novartis, Basel, Switzerland., Jiang L; Drug Metabolism and Pharmacokinetics, Vertex Pharmaceuticals, Inc., San Diego, CA, USA., Vourvahis M; Pfizer Inc., Research and Development, New York, NY, USA., Pajkovic N; Pharmacokinetics, Dynamics, Metabolism and Bioanalytics, Merck & Co. Inc., Rahway, NJ, USA., Parrott N; Roche Pharmaceutical Research and Early Development, Roche Innovation Center, F. Hoffmann-La Roche Ltd., Basel, Switzerland., Thakkar N; GSK, 1250 S Collegeville Road, Collegeville, PA, USA., Marroum P; Clinical Pharmacology, Abbvie, Bldg AP31, 1 North Waukegan Road, North Chicago, IL, USA., Laethem R; Clinical Pharmacology & DMPK, Alkermes, 900 Winter Street, Waltham, MA, USA., Xu S; Preclinical Sciences & Translational Safety, Johnson & Johnson Innovative Medicine, Spring House, PA, USA., Chen Y; Genentech Inc., South San Francisco, CA, USA. |
